OncoCyte Corp (OCX)
2.66
-0.12
(-4.30%)
USD |
NASDAQ |
May 03, 16:00
2.69
+0.03
(+1.13%)
Pre-Market: 20:00
OncoCyte Shareholders Equity (Quarterly): 20.47M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 20.47M |
September 30, 2023 | 37.56M |
June 30, 2023 | 43.60M |
March 31, 2023 | 37.93M |
December 31, 2022 | 34.29M |
September 30, 2022 | 76.86M |
June 30, 2022 | 88.10M |
March 31, 2022 | 56.97M |
December 31, 2021 | 65.22M |
September 30, 2021 | 99.35M |
June 30, 2021 | 102.67M |
March 31, 2021 | 106.63M |
December 31, 2020 | 33.48M |
September 30, 2020 | 34.64M |
June 30, 2020 | 39.59M |
March 31, 2020 | 36.62M |
December 31, 2019 | 30.84M |
September 30, 2019 | 29.34M |
Date | Value |
---|---|
June 30, 2019 | 33.50M |
March 31, 2019 | 38.19M |
December 31, 2018 | 3.423M |
September 30, 2018 | 7.523M |
June 30, 2018 | 6.846M |
March 31, 2018 | 9.022M |
December 31, 2017 | 4.403M |
September 30, 2017 | 8.048M |
June 30, 2017 | 5.639M |
March 31, 2017 | 8.773M |
December 31, 2016 | 9.862M |
September 30, 2016 | 12.68M |
June 30, 2016 | 4.467M |
March 31, 2016 | 6.895M |
December 31, 2015 | 10.42M |
September 30, 2015 | 8.942M |
December 31, 2014 | -1.074M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
20.47M
Minimum
Dec 2023
106.63M
Maximum
Mar 2021
53.03M
Average
37.93M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
Fonar Corp | 163.89M |
XWELL Inc | 13.00M |
ProPhase Labs Inc | 49.38M |
Applied DNA Sciences Inc | 4.232M |
Veracyte Inc | 1.044B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 74.89M |
Total Liabilities (Quarterly) | 54.42M |
Current Ratio | 1.487 |